Poly(lactic-co-glycolic acid) nanospheres and microspheres for short- and long-term delivery of bioactive ciliary neurotrophic factor.
Ciliary neurotrophic factor (CNTF) has been shown to be neuroprotective in the central nervous system (CNS). However, systemic administration and bolus injections have shown significant side effects and limited efficacy. Sustained, local delivery may lead to effective neuroprotection and avoid or limit adverse side effects, but sustained CNTF delivery has proven difficult to achieve and control. For controlled, sustained delivery, we investigated several processing variables in making poly(DL-lactic-co-glycolic acid) (PLGA) nano- and microspheres to optimize CNTF encapsulation and release. Nano- and microspheres were 314.9 +/- 24.9 nm and 11.69 +/- 8.16 microm in diameter, respectively. CNTF delivery from nanospheres was sustained over 14 days, and delivery from microspheres continued over more than 70 days. To assess protein bioactivity after encapsulation, neural stem cells (NSCs) were treated with CNTF released from nanospheres and compared to those treated with unencapsulated CNTF as a control. NSCs treated with CNTF expressed markers specific to mature cells, notably astrocytes; some increase in oligodendrocytic and neuronal marker expression was also observed. Significantly, cells treated with CNTF released by nanospheres exhibited a similar degree of differentiation when compared to those treated with control CNTF of equivalent concentration, showing that the process of protein encapsulation did not reduce its potency.
Nkansah
Michael K
MK
Department of Biomedical Engineering, Yale University, 55 Prospect Street, New Haven, Connecticut 06511, USA.
Tzeng
Stephany Y
SY
Holdt
Adam M
AM
Lavik
Erin B
EB
D002214:Capsules; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D020934:Ciliary Neurotrophic Factor / Q000008:administration & dosage* / Q000737:chemistry*; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000737:chemistry*; D006801:Humans; D019344:Lactic Acid / Q000737:chemistry*; D008422:Materials Testing; D049329:Nanostructures / Q000737:chemistry* / Q000648:ultrastructure; D009474:Neurons / Q000166:cytology* / Q000187:drug effects; D010316:Particle Size; D011100:Polyglycolic Acid / Q000737:chemistry*; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D013234:Stem Cells / Q000166:cytology* / Q000187:drug effects
D002214:Capsules; D020934:Ciliary Neurotrophic Factor; D003692:Delayed-Action Preparations; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid